Biomaterials Market Size to grow by USD 12759.4 million between 2024-2028

Technavio, a leading provider of market research reports, has released its latest study on Biomaterials Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. The global biomaterials market is experiencing significant growth due to the increasing number of outpatient joint replacement surgeries worldwide. Arthroplasty procedures, including knee, hip, shoulder replacement, and trauma and extremities reconstruction, are on the rise, with many now performed on an outpatient basis for patients with no major medical or psychiatric complications. Advancements in surgical techniques, implants, comprehensive blood management, multimodal pain management, and post-operative care have led to reduced hospital stays and eliminated the need for extensive formal rehabilitation. This shift to outpatient joint replacement surgeries offers numerous benefits, such as shorter hospital stays, increased patient satisfaction, and cost savings for both healthcare systems and patients.

Key Highlights

Growth Projections

The global biomaterials market  size is estimated to grow by USD 12759.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  5.68% during the forecast period. Increasing prevalence of musculoskeletal diseases and disorders is driving market growth, with a trend towards increasing number of joint replacement and arthroplasty surgeries  However, high cost of bioimplants and surgeries  poses a challenge.Key market players include Algenesis Corp., Artoss Inc., BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, Carpenter Technology Corporation, Celanese Corp., CeramTec GmbH, CoorsTek Inc., Corbion nv, Covestro AG, Dimension Inx., Evonik Industries AG, Gelita AG, Koninklijke DSM NV, Mitsubishi Chemical Group Corp., Noble Biomaterials Inc., Riton Biomaterial Co. Ltd., Victrex Plc, and Zeus Co. Inc..

Know what is trending in the market - Access a free sample report! 

Major Findings

• The biomaterials market is experiencing significant growth due to the rising prevalence of musculoskeletal diseases and disorders. These conditions, which affect the muscles, bones, and connective tissues, are increasingly common, particularly in aging populations. Biomaterials, such as hydrogels, ceramics, and polymers, offer promising solutions for the development of advanced therapies and medical devices to treat these conditions. Their biocompatibility, strength, and ability to promote tissue regeneration make them indispensable in orthopedics, dentistry, and other medical fields. The market for biomaterials in musculoskeletal applications is expected to expand at a robust pace in the coming years.


• The biomaterials market is experiencing significant growth due to the increasing demand for advanced wound healing therapies. Biomaterials, such as hydrogels, scaffolds, and skin substitutes, are essential components in the development of innovative wound care solutions. These materials facilitate tissue regeneration, promote healing, and reduce scarring, making them indispensable in various medical applications. The market's expansion is driven by the rising prevalence of chronic wounds, increasing geriatric population, and technological advancements in biomaterials research and development.


• The Biomaterials Market faces a significant challenge due to the high cost associated with bioimplants and surgeries. These expenses can be attributed to the complex production processes and the use of advanced technologies. The high cost is a major barrier for widespread adoption, particularly in developing countries. However, ongoing research and development efforts aim to reduce costs and make these life-enhancing solutions more accessible to a larger population.


• Biomaterials, essential components in various medical applications, undergo stringent clinical and regulatory processes to ensure safety and efficacy. These processes include rigorous testing, clinical trials, and regulatory approvals. Compliance with these procedures is crucial to bring biomaterials to market and improve patient outcomes. The regulatory landscape is complex, with agencies such as the FDA and EU MDR enforcing strict guidelines. Adherence to these guidelines is essential to gain market approval and maintain market leadership.

Market Research Overview

According to Technavio, the biomaterials market under consideration falls under the expansive umbrella of the global healthcare equipment industry. This sector encompasses organizations involved in the R&D of diverse product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are integral to the diagnosis, monitoring, and treatment of various diseases. The size of the global healthcare equipment market is determined by the collective revenue generated by manufacturers of diagnostic devices and equipment across various therapy areas. The healthcare equipment sector is segmented into Devices, which includes advanced, differentiated, and clinically validated data-driven devices.

The Biomaterials Market is experiencing significant growth, fueled by the Increasing prevalence of musculoskeletal diseases and disorders. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

For insights on company offerings- Request a sample report!

Regional Insights

The biomaterials market represents a significant growth opportunity for businesses, driven by the increasing demand for advanced medical devices, tissue engineering, and drug delivery systems. Key players in this sector focus on developing innovative solutions that address unmet medical needs, utilizing materials such as hydrogels, polymers, and ceramics. Market expansion is further fueled by regulatory approvals, collaborations, and investments in research and development.

Research Analysis Overview

The biomaterials market is experiencing significant growth due to the development of innovative solutions in healthcare. Investments in eco-friendly alternatives to traditional materials are driving the market forward, with a focus on biologically derived materials and bioengineering. One exciting area is the creation of 3D printable biomaterials, which offer the potential for customized implants and constructs, including polymeric constructs, allograft-based treatments, and autologous treatments. Nanotechnology is also playing a major role in the biomaterials market, with applications in implants, medical devices, and therapeutic areas. Nanotechnology enables sustained therapeutic levels of therapeutic agents through controlled release kinetics, enhancing cellular uptake and improving treatment efficacy. Hydrogels, microspheres, and nanoparticles are among the most commonly used biomaterials for drug delivery systems. Ceramics and metallic biomaterials are also popular, with applications in orthopedic applications, implantable devices, and plastic surgery. Bioabsorbable biomaterials are gaining popularity due to their biocompatibility and ability to promote tissue regeneration. Personalized medicine and regenerative medicine are also driving the market, with the potential to revolutionize healthcare through the development of implantable devices and advanced wound healing treatments. Overall, the biomaterials market is a dynamic and rapidly evolving field, with a wide range of applications in healthcare and therapeutic areas. From nanotechnology to bioengineering, the future of biomaterials is bright, with the potential to transform healthcare and improve patient outcomes.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/